$RFL-WT News
Last published 1w ago
- 1w agoRFLRFL-WTRafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceGlobeNewswireNEWARK, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE:RFL) today announced that it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on
- 1w agoRFLRFL-WTRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateGlobeNewswireNEWARK, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE:RFL) today reported its financial results for the fourth quarter and full fiscal year 2026 ended July 31, 2026. Fiscal 2026 and Recent
- 1w agoRFLRFL-WTRafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type CGlobeNewswireNDA supported by the Phase 3 TransportNPC™ study, data from earlier clinical studies, and an overall survival analysis versus external registry controls Remibetadex has received Orphan Drug, Fast Track and Rare